Semi-Annual Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7734310

Concept 2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,832,165,000 JPY
3,123,920,000 JPY
3,555,847,000 JPY
3,250,936,000 JPY
Non-operating income
Non-operating income
169,270,000 JPY
156,480,000 JPY
210,229,000 JPY
219,065,000 JPY
Non-operating expenses
Non-operating expenses
122,607,000 JPY
112,990,000 JPY
52,369,000 JPY
48,633,000 JPY
Ordinary profit (loss)
3,878,829,000 JPY
3,167,410,000 JPY
3,713,707,000 JPY
3,421,369,000 JPY
Extraordinary income
Extraordinary income
292,204,000 JPY
290,504,000 JPY
17,757,000 JPY
1,250,000 JPY
Extraordinary losses
Extraordinary losses
285,830,000 JPY
285,814,000 JPY
305,413,000 JPY
298,803,000 JPY
Profit (loss) before income taxes
3,885,202,000 JPY
3,172,099,000 JPY
3,426,050,000 JPY
3,123,815,000 JPY
Income taxes - current
1,405,768,000 JPY
1,132,000,000 JPY
917,708,000 JPY
764,000,000 JPY
Income taxes - deferred
-147,582,000 JPY
-116,425,000 JPY
-39,010,000 JPY
-17,630,000 JPY
Profit (loss)
2,156,524,000 JPY
2,156,524,000 JPY
2,627,016,000 JPY
2,156,524,000 JPY
2,156,524,000 JPY
2,377,446,000 JPY
2,547,351,000 JPY
2,377,446,000 JPY
2,377,446,000 JPY
2,377,446,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.